132 related articles for article (PubMed ID: 11205360)
1. Is multiple sclerosis severity a genetically influenced trait?
Cocco E; Marrosu MG
Neurol Sci; 2000; 21(4 Suppl 2):S843-7. PubMed ID: 11205360
[TBL] [Abstract][Full Text] [Related]
2. Identifying disease modifying genes in multiple sclerosis.
Kantarci OH; de Andrade M; Weinshenker BG
J Neuroimmunol; 2002 Feb; 123(1-2):144-59. PubMed ID: 11880159
[TBL] [Abstract][Full Text] [Related]
3. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis.
Ballerini C; Campani D; Rombolà G; Gran B; Nacmias B; Amato MP; Siracusa G; Bartolozzi L; Sorbi S; Massacesi L
Neurosci Lett; 2000 Dec; 296(2-3):174-6. PubMed ID: 11109009
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
6. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.
Luomala M; Lehtimäki T; Elovaara I; Wang X; Ukkonen M; Mattila K; Laippala P; Koivula T; Hurme M
J Neurol Sci; 2001 Apr; 185(2):123-7. PubMed ID: 11311293
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
J Neurol Sci; 2000 Oct; 179(S 1-2):70-5. PubMed ID: 11054488
[TBL] [Abstract][Full Text] [Related]
8. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
van Winsen LM; Hooper-van Veen T; van Rossum EF; Koper JW; Barkhof F; Polman CH; Uitdehaag BM
J Neuroimmunol; 2007 May; 186(1-2):150-5. PubMed ID: 17395275
[TBL] [Abstract][Full Text] [Related]
10. No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
Ramagopalan SV; Deluca GC; Morrison KM; Herrera BM; Dyment DA; Orton S; Bihoreau MT; Degenhardt A; Pugliatti M; Sadovnick AD; Sotgiu S; Ebers GC
J Neuroimmunol; 2007 May; 186(1-2):156-60. PubMed ID: 17376543
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
12. The genetics of clinical outcome in multiple sclerosis.
Ramagopalan SV; Deluca GC; Degenhardt A; Ebers GC
J Neuroimmunol; 2008 Sep; 201-202():183-99. PubMed ID: 18632165
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of a gene for multiple sclerosis (MS) to chromosome region 19q13.3.
Lucotte GL;
Genet Couns; 2002; 13(2):133-8. PubMed ID: 12150212
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene.
Tienari PJ; Wikström J; Sajantila A; Palo J; Peltonen L
Lancet; 1992 Oct; 340(8826):987-91. PubMed ID: 1383661
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
[TBL] [Abstract][Full Text] [Related]
16. Association of APOE polymorphisms with disease severity in MS is limited to women.
Zwemmer J; Uitdehaag B; van Kamp G; Barkhof F; Polman C
Neurology; 2004 Sep; 63(6):1139; author reply 1139. PubMed ID: 15452327
[No Abstract] [Full Text] [Related]
17. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
[TBL] [Abstract][Full Text] [Related]
18. No linkage or association of the nitric oxide synthase genes to multiple sclerosis.
Modin H; Dai Y; Masterman T; Svejgaard A; Sørensen PS; Oturai A; Ryder LP; Spurkland A; Vartdal F; Laaksonen M; Sandberg-Wollheim M; Myhr KM; Nyland H; Hillert J
J Neuroimmunol; 2001 Sep; 119(1):95-100. PubMed ID: 11525805
[TBL] [Abstract][Full Text] [Related]
19. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
[TBL] [Abstract][Full Text] [Related]
20. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.
Bugeja MJ; Booth D; Bennetts B; Heard R; Rubio J; Stewart G
BMC Med Genet; 2006 Jul; 7():64. PubMed ID: 16872505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
